1. Agewall S., Beltrame J. F., Reynolds H. R., Niessner A., Rosano G., Caforio A. L., De Caterina R., Zimarino M., Roffi M., Kjeldsen K., Atar D., Kaski J. C., Sechtem U., Tornvall P.; Working Group on Cardiovascular Pharmacotherapy. ESC Working Group position paper on myocardial infarction with non-obstructive coronary arteries. Eur. Heart J. 2017; 38: 143–153.
2. Raparelli V., Elharram M., Shimony A., Eisenberg M. J., Cheema A. N., Pilote L. Myocardial Infarction With No Obstructive Coronary Artery Disease: Angiographic and Clinical Insights in Patients With Premature Presentation. Can. J. Cardiol. 2018; 34: 468–476.
3. Lindahl B., Baron T., Erlinge D., Hadziosmanovic N., Nordenskjöld A. M., Gard A., Jernberg T. Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease. Circulation. 2017; 135: 1481–1489.
4. Pasupathy S., Air T., Dreyer R. P., Tavella R., Beltrame J. F. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015; 131: 861–870.
5. Emrich T., Emrich K., Abegunewardene N., Oberholzer K., Dueber C., Muenzel T., Kreitner K. F. Cardiac MR enables diagnosis in 90% of patients with acute chest pain, elevated biomarkers and unobstructed coronary arteries. Br. J. Radiol. 2015; 88(1049): 20150025.